[1]钟 灼,高 飞,邱振康,等.“双夹心法”碳酸氢钠联合TACE治疗巨块型肝癌研究[J].介入放射学杂志,2022,31(01):83-87.
　ZHONG Zhuo,GAO Fei,QIU Zhenkang,et al.TACE combined with “double sandwich method” infusion of sodium bicarbonate for the treatment of massive hepatocellular carcinoma[J].journal interventional radiology,2022,31(01):83-87.

点击复制

“双夹心法”碳酸氢钠联合TACE治疗巨块型肝癌研究()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ Wu H， Ding Z， Hu D， et al. Central role of lactic acidosis in cancer cell resistance to glucose deprivation- induced cell death［J］. J Pathol， 2012， 227： 189- 199.
［2］ Chao M， Wu H， Jin K， et al. A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis［J］. Elife， 2016， 5： e15691.
［3］ 杨秉辉，夏景林. 原发性肝癌的临床诊断与分期标准［J］. 中华肝脏病杂志， 2001， 9：324.
［4］ 朱 楠，张甜甜，吕维富，等． 影像学诊断中晚期肝癌TACE术后活性病灶［J］． 中国介入影像与治疗学， 2019， 16：173- 177．
［5］ 高 杨，纪建松，杨宏远，等． 影像学检查在肝癌外科术后甲胎蛋白阴性患者随访中的价值［J］． 介入放射学杂志， 2016， 25：355- 359．
［6］ 李书有． 肝癌分子靶向药物治疗影像学疗效评价进展［J］． 影像研究与医学应用， 2019， 3：1- 2．
［7］ Kudo M， Matsui O， Izumi N， et al. Transarterial chemoembolization failure/refractoriness：JSH- LCSGJ criteria 2014 update［J］. Oncology， 2014， 87： 22- 31.
［8］ Raoul JL， Gilabert M， Piana G. How to define transarterial chemo- embolization failure or refractoriness： a European perspective［J］. Liver Cancer， 2014， 3： 119- 124.
［9］ Zhang SS， Liu JX， Zhu J， et al. Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma： a meta- analysis［J］. Jpn J Clin Oncol， 2019， 49： 646- 655.
［10］ 卢思聪，任启洪，黄 晴，等． 中晚期原发性肝癌肝动脉化疗栓塞术后常规超声与超声造影引导下射频消融的疗效比较［J］．中国普外基础与临床杂志， 2018， 25：1318- 1322．

［11］ He MK， Le Y， Qj L， et al. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma： a prospective non- rando-mized study［J］. Chin J Cancer， 2017， 36： 83.

［12］ 鲍 淼，袁洪胜． 微波消融联合肝动脉插管化疗栓塞术治疗巨块型肝癌的中期临床研究［J］． 中国临床研究， 2019， 52：1353- 1356．

［13］ Jiang XY， Han X， Zhang TQ， et al. Transcatheter arterial chemoembolization combined with simultaneous cone beam computed tomography- guided multipolar microwave ablation for massive hepatocellular carcinoma（＞10 cm）： safety and primary clinical results［J］. J Intervent Med， 2019， 2： 65- 68.

［14］ Cui W， Fan W， Huang K， et al. Large hepatocellular carcinomas： treatment with transarterial chemoembolization alone or in com-bination with percutaneous cryoablation［J］. Int J Hyperthermia， 2018， 35： 239- 245.

［15］ 严守美，崔新江，于志军，等． 经肝动脉化疗栓塞联合微波消融治疗巨块型肝癌术前中性粒细胞与淋巴细胞比率监测的临床意义［J］． 介入放射学杂志， 2018， 27：632- 635．

［16］ 张 源，翟 博． 大肝癌的微创介入治疗［J］． 介入放射学杂志， 2019， 28：394- 399．

［17］ Vander Heiden MG， Cantley LC， Thompson CB. Understanding the warburg effect： the metabolic requirements of cell proliferation［J］. Science， 2009， 324： 1029- 1033.

［18］ Xie J， Wu H， Dai C， et al. Beyond warburg effect- dual metabolic nature of cancer cells［J］. Sci Rep， 2014， 4： 4927.

［19］ Fu LQ， Du WL， Cai MH， et al. The roles of tumor- associated macrophages in tumor angiogenesis and metastasis［J］. Cell Immu-nol， 2020， 353： 104119.

［20］ Saravanan S， Vimalraj S， Pavani K， et al. Intussusceptive angiogenesis as a key therapeutic target for cancer therapy［J］. Life Sci， 2020， 252： 117670.

［21］ 汪思亮，盛晓波，韦忠红，等． 肿瘤血管正常化与肿瘤治疗［J］．肿瘤， 2013， 33：653- 657．

［22］ Ming C， Hao W， Kai J， et al. TILA- TACE- an approach for effective local control of hepatocellular carcinoma［J］. J Intervent Med， 2018， 1： 58- 63.

［23］ 宁 振，谭 广． 肿瘤代谢：肝癌精准诊疗新视角［J］． 中华外科杂志， 2020， 58：31- 36．

［24］ 赵 宇，刘志刚，王 晖． 乳酸异常代谢与肿瘤的研究进展［J］．中华肿瘤防治杂志， 2015， 22：239- 242．

相似文献/References:

[1]倪鎏达,陈成伟,鲁进宇,等.靛氰氯排泄试验在肝癌治疗中应用价值[J].介入放射学杂志,1996,(01):23.
[2]刘新献,龙清云,胡金香,等.ＴＡＣＥ联合血管内皮抑素治疗兔ＶＸ２肝癌ＣＴ灌注与肿瘤血管生成的分析[J].介入放射学杂志,2010,(11):893.
　LIU Xin-xian,LONG Qing-yun,HU Jin-xiang,et al.TACE combined with endostatin for the treatment of rabbit VX2 hepatic carcinoma: an analysis of the correlation between CT perfusion parameters and tumor angiogenesis[J].journal interventional radiology,2010,(01):893.
[3]孟冉冉,赵广生,张跃伟.明胶海绵微粒联合TACE治疗肝癌合并弥漫性动静脉瘘一例[J].介入放射学杂志,2012,(11):896.
　MENG Ran? ran,ZHAO Guang? sheng,ZHANG Yue? wei.. Gelatin sponge particles combined with TACE for the treatment of hepatocellular carcinoma complicated by diffuse arteriovenous fistula： report of one case[J].journal interventional radiology,2012,(01):896.
[4]陶超超,张鸿文,吴纪瑞. 原发性肝癌TACE术后肺部炎症的影像表现及原因分析[J].介入放射学杂志,2012,(12):1038.
　TAO Chao? chao,ZHANG Hong? wen,WU Ji? rui.. Pulmonary inflammation occurring after TACE for primary hepatocellular carcinoma： its imaging features and an analysis of its causes[J].journal interventional radiology,2012,(01):1038.
[5]迟秀婷,沈加林,程杰军,等.CT灌注成像对评估12例5 cm以下肝癌介入治疗疗效 [J].介入放射学杂志,2014,(09):772.
　CHI Xiu ting,SHEN Jia lin,CHENG Jie jun,et al.Application of CT perfusion imaging in evaluating interventional therapy for small hepatocellular carcinoma： preliminary experience in 12 cases[J].journal interventional radiology,2014,(01):772.
[6]迟秀婷,沈加林. 肝癌TACE治疗效果的影像学评估[J].介入放射学杂志,2013,(08):694.
　CHI Xiu? ting,SHEN Jia? lin.. Imaging evaluation of transcatheter arterial chemoembolization in treating hepatocellular carcinomas[J].journal interventional radiology,2013,(01):694.
[7]徐 松,朱林忠,朱 旭.原发性肝癌介入治疗术中迷走神经反射的防治[J].介入放射学杂志,2014,(12):1077.
　XU Song,ZHU Lin zhong,ZHU Xu..Prevention and treatment of vasovagal reactions occurring during TACE therapy for primary liver cancer[J].journal interventional radiology,2014,(01):1077.
[8]曹耿飞,纪卫政,顾俊鹏,等.贝伐单抗联合TACE治疗TACE 抵抗性肝癌13例疗效观察[J].介入放射学杂志,2015,(01):69.
　CAO Geng fei,JI Wei zheng,GU Jun peng,et al.Transarterial infusion of bevacizumab combined with TACE for the treatment of TACE refractory HCC： therapeutic analysis of 13 cases[J].journal interventional radiology,2015,(01):69.
[9]杨 凯,程英升,杨继金,等.肝脏原发性神经内分泌癌伴肝内多发转移1例并文献复习[J].介入放射学杂志,2015,(04):354.
　YANG Kai,CHENG Ying sheng,YANG Ji jin,et al.Primary hepatic neuroendocrine tumor accompanied with multiple hepatic metastases： report of one case with literature review[J].journal interventional radiology,2015,(01):354.
[10]叶伟东,纪建松,涂建飞,等.氩氦刀冷冻消融联合肝动脉栓塞化疗术治疗中晚期肝癌的疗效分析[J].介入放射学杂志,2015,(05):392.
　YE Wei dong,JI Jian song,TU Jian fei,et al.Argon helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma： analysis of therapeutic effectiveness[J].journal interventional radiology,2015,(01):392.